(Q42547837)

2 November 2017

Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure (English)

1 reference

2 November 2017

0 references

1 reference

1 reference

congestive heart failure

1 reference

1

1 reference

2 November 2017

Weissgarten J

2

1 reference

2 November 2017

Metzkor E

3

1 reference

2 November 2017

Moshkovitz Y

4

1 reference

2 November 2017

Litinski I

5

1 reference

2 November 2017

Tavori U

6

1 reference

2 November 2017

Perry C

7

1 reference

2 November 2017

Zaidenstein R

8

1 reference

2 November 2017

Golik A

9

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Clinical Pharmacology & Therapeutics

2 November 2017

1 reference

2 November 2017

62

1 reference

2 November 2017

2

1 reference

2 November 2017

187-193

1 reference

Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man.

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Dopamine and the kidney: ten years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Electrophysiologic and proarrhythmic effects of intravenous inotropic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

High dose furosemide in refractory cardiac failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Synergism of dopamine plus furosemide in preventing acute renal failure in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Dopamine and frusemide in oliguric acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Acute effects of furosemide on blood pressure in functionally anephric, volume-expanded rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Direct vasoactivity of frusemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990067-9

10.1016/S0009-9236(97)90067-9

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference